Aminologics Co Ltd is a Korea-based company primarily engaged in the raw pharmaceutical ingredient business.The Company operates its business through two segments. The Raw Pharmaceutical Ingredient segment supplies raw pharmaceutical ingredients for stroke, eye disease, dermatitis and cosmetics. The Amino Acid segment manufactures and sells amino acid derivatives and other compounds. The Company sells its products in domestic and overseas markets.

Employees

Sector

Pharmaceuticals

More about the company

Quotes

Date	Price	Change	Volume
26-10-23	₩989.00	-0.40%	58,551
26-10-22	₩993.00	0.00%	34,284
26-10-21	₩993.00	-2.17%	40,412
26-10-20	₩1,015.00	+0.10%	81,521
26-10-19	₩1,014.00	0.00%	28,234

End-of-day quote Korea S.E.

More quotes

End-of-day quote Korea S.E. 2026-10-23			5-day change	1st Jan Change
989.00 ^KRW	-0.40%		-2.47%	-17.17%

25-06-29	Aminologics Co.,Ltd. announced that it has received KRW 20 billion in funding from Sam-Oh Pharm Co. Ltd, Korea Investment & Securities Co., Ltd., NH Investment & Securities Co., Ltd., KB Securities Co., Ltd., Samsung Securities Co.,Ltd.	CI
25-06-25	Aminologics Co.,Ltd. announced that it expects to receive KRW 20 billion in funding from Sam-Oh Pharm Co. Ltd, Korea Investment & Securities Co., Ltd., NH Investment & Securities Co., Ltd., KB Securities Co., Ltd., Samsung Securities Co.,Ltd.	CI

Market Cap	87.17B 65.8M 58.76M 54.28M 49.19M 92.03M 6.25B 93.56M 653M 259M 3.27B 247M 242M 10.32B	P/E 2024	-48.7x	P/E 2025	29.8x
Enterprise Value	40.35B 30.46M 27.2M 25.13M 22.77M 42.6M 2.89B 43.31M 302M 120M 1.52B 114M 112M 4.78B	EV / Sales 2024	2.71x	EV / Sales 2025	2.64x
Free-Float	67.84%	Yield 2024 *	-	Yield 2025	-

25-06-29	Aminologics Co.,Ltd. announced that it has received KRW 20 billion in funding from Sam-Oh Pharm Co. Ltd, Korea Investment & Securities Co., Ltd., NH Investment & Securities Co., Ltd., KB Securities Co., Ltd., Samsung Securities Co.,Ltd.	CI
25-06-25	Aminologics Co.,Ltd. announced that it expects to receive KRW 20 billion in funding from Sam-Oh Pharm Co. Ltd, Korea Investment & Securities Co., Ltd., NH Investment & Securities Co., Ltd., KB Securities Co., Ltd., Samsung Securities Co.,Ltd.	CI
23-09-18	Aminologics Co.,Ltd.(KOSDAQ:A074430) dropped from S&P Global BMI Index	CI
23-05-15	Aminologics Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
16-09-19	Aminologics Co., Ltd.(KOSDAQ:A074430) added to S&P Global BMI Index	CI
16-04-27	Daeduk Green Energy Limited Company cancelled the acquisition of 10.21% stake in Daejeon Cogeneration Plant Co., Ltd. from Aminologics Co., Ltd..	CI
15-04-27	Daeduk Green Energy Limited Company signed a contract to acquire 10.21% stake in Daejeon Cogeneration Plant Co., Ltd. from Aminologics Co., Ltd. for KRW 4.6 billion.	CI
14-02-27	An unknown buyer cancelled the acquisition of 84.35% stake in U-Chang Plant Engineering & Construction Co., Ltd. from Aminologics Co., Ltd..	CI
13-12-12	LG Life Sciences Not To Acquire Aminologics	CI
13-02-27	An unknown buyer agreed to acquire 84.35% stake in U-Chang Plant Engineering & Construction Co., Ltd. from Aminologics Co., Ltd. for KRW 7.7 billion.	CI

1 day	-0.40%
1 week	-2.47%
Current month	-5.36%
1 month	-7.31%
3 months	-6.26%
6 months	-34.24%
Current year	-17.17%

Aminologics Co.,Ltd. Stock

Stocks

A074430

KR7074430000

Pharmaceuticals

Valuation: Aminologics Co.,Ltd.

Chart: Aminologics Co.,Ltd.

Latest news: Aminologics Co.,Ltd.

Quotes and Performance

Price Extremes

Managers and Directors: Aminologics Co.,Ltd.

Latest insider transactions

Other Pharmaceuticals

Financials

Company Profile

Quotes

1 week	930	1,023
1 month	930	1,119
Current year	930	1,940
1 year	855	1,940
3 years	847	1,950
5 years	847	3,230
10 years	847	4,355

Manager	Title	Age	Since
Seong-Seok Oh CEO	Chief Executive Officer	71	-
Jang-Seok Oh CEO	Chief Executive Officer	74	2014-03-26
Seung-Ye Oh PSD	President	41	-

Director	Title	Age	Since
Jang-Seok Oh BRD	Director/Board Member	74	2014-03-26
Seong-Seok Oh BRD	Director/Board Member	71	-
Joo-Hyeong Oh BRD	Director/Board Member	44	-

Date	Insider	Type	Main position	Quantity	% Market Cap.
1/25/24	Jang-Seok Oh	Buy	Chief Executive Officer	29,100	0.0331%
1/25/24	Seong-Seok Oh	Buy	Chief Executive Officer	29,100	0.0331%
1/25/24	Jang-Seok Oh	Buy	Chief Executive Officer	18,000	0.0205%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
AMINOLOGICS CO.,LTD.	-0.40%	-2.47%	+2.70%	-17.03%	65.8M
ELI LILLY AND COMPANY	-2.54%	+1.31%	+54.27%	+114.96%	1,135B
JOHNSON & JOHNSON	-1.42%	+3.23%	+38.56%	+74.44%	635B
ABBVIE INC.	+0.16%	+0.08%	+25.29%	+95.23%	505B
ROCHE HOLDING AG	-0.31%	+3.09%	+44.14%	+64.80%	378B
MERCK & CO., INC.	-1.34%	-0.47%	+66.04%	+41.00%	358B
NOVARTIS AG	-0.68%	+2.65%	+22.98%	+50.39%	295B
ASTRAZENECA PLC	-1.20%	+3.04%	+2.33%	+22.86%	266B
AMGEN INC.	-1.79%	+1.57%	+50.56%	+59.08%	237B
GILEAD SCIENCES, INC.	-0.73%	-0.10%	+29.02%	+99.67%	193B
Average	-1.02%	+1.70%	+33.59%	+60.54%	400.37B
Weighted average by Cap.	-1.35%	+2.66%	+41.02%	+79.75%

	2024	2025
Net sales	16.79B 12.67M 11.32M 10.46M 9.48M 17.73M 1.2B 18.02M 126M 49.81M 630M 47.56M 46.55M 1.99B	22.02B 16.62M 14.84M 13.71M 12.43M 23.25M 1.58B 23.63M 165M 65.33M 827M 62.38M 61.05M 2.61B
Net income	-1.62B -1.22M -1.09M -1.01M -914K -1.71M -116M -1.74M -12.14M -4.81M -60.82M -4.59M -4.49M -192M	3.52B 2.66M 2.37M 2.19M 1.99M 3.72M 252M 3.78M 26.39M 10.45M 132M 9.98M 9.76M 417M
Net Debt	-33.36B -25.18M -22.49M -20.78M -18.83M -35.22M -2.39B -35.81M -250M -98.98M -1.25B -94.52M -92.51M -3.95B	-46.82B -35.34M -31.56M -29.15M -26.42M -49.43M -3.35B -50.25M -351M -139M -1.76B -133M -130M -5.54B